BASIC SEMI (09971.HK): H1 2026 Revenue Rises to RMB 121 Million as Gross Margin Turns Positive, Loss Narrows 8.8%
- The adjusted net loss (non-IFRS) was approximately RMB 112 million, narrowing 15.1% year on year.
- Revenue from industrial-grade SiC power modules surged 2,825.1% and SiC MOSFET revenue grew 582.3%.
- The Company's H shares were listed on the Main Board on 8 July 2026, with over 60 new module customers added.
NewTimeSpace News: On 22 September 2026, Shenzhen BASiC Semiconductor Co., Ltd. (stock code: 09971) published its interim report for the six months ended 30 June 2026. Revenue reached approximately RMB 121 million, up 15.5% year on year, and loss for the period was approximately RMB 162 million, narrowing 8.8% from a year earlier.
The announcement disclosed that the Group's overall gross margin improved to 2.8% from negative 28.8% a year earlier, a gain of 31.6 percentage points, marking a milestone of positive gross margin. The adjusted net loss (non-IFRS measure) was approximately RMB 112 million, narrowing 15.1%. Revenue from industrial-grade silicon carbide power modules surged 2,825.1% year on year, and silicon carbide MOSFET revenue grew 582.3%, as emerging application scenarios accelerated adoption.
The Company's H shares were listed on the Main Board of the Stock Exchange on 8 July 2026. During the period, the Group continued R&D and platform iteration across three product directions — silicon carbide discrete devices, silicon carbide power modules and power semiconductor gate drivers — and expanded its customer base, adding over 60 new customers for industrial-grade silicon carbide power modules. The board does not recommend an interim dividend.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- ZUOLI KECHUANG (06866.HK): Chairman Transfers 88m Domestic Shares, Controlling Holder at 35.98%
- TYK MEDICINES-B (02410.HK): First Kadasa Batch Due 18 November, Shipping by Month-End
- HOSIN (02681.HK): Offer Price Fixed at HK$72.83; HK Offer 2.37 Times Covered
- DEEP SOURCE (00990.HK): Kuantan AI Data Centre Plan Detailed; Land Costs MYR417m
- PIOLET BIOTECHNOLOGY: Closes RMB 10 Million-Plus Seed Round Led by Trinity Capital, Taking Antivirulins Into Drug-Resistant Infections